Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians

Abstract

ACP recommends against the use of erythropoiesis-stimulating agents in patients with mild to moderate anemia and congestive heart failure or coronary heart disease. (Grade: strong recommendation; moderate-quality evidence).